Treatment for High Blood Sugar
High blood sugar, also known as hyperglycemia, is a hallmark of diabetes mellitus, affecting millions worldwide. In type 1 diabetes, the body lacks insulin production, while type 2 diabetes involves insulin resistance. Untreated hyperglycemia can lead to complications like diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS). Effective treatment revolves around restoring normal glucose levels, typically below 140 mg/dL fasting or under 180 mg/dL post-meal, as per American Diabetes Association (ADA) guidelines. This article explores evidence-based strategies, from lifestyle interventions to pharmacological options.
Lifestyle Modifications
Foundational to managing hyperglycemia are dietary adjustments and physical activity. A carbohydrate-controlled diet limits intake to 45-60 grams per meal, emphasizing low-glycemic index foods like leafy greens, nuts, and lean proteins. Portion control prevents spikes, while fiber-rich foods slow glucose absorption. For instance, the Mediterranean diet has shown to lower HbA1c by 0.3-2% in clinical trials.
Transitioning to exercise, regular aerobic activity—such as 150 minutes weekly of brisk walking or cycling—enhances insulin sensitivity. Resistance training twice weekly builds muscle, aiding glucose uptake. Patients should monitor blood sugar before and after workouts to avoid hypoglycemia. Hydration is crucial, as dehydration exacerbates hyperglycemia.
Pharmacological Treatments
Medications complement lifestyle changes. Metformin, a first-line therapy for type 2 diabetes, reduces hepatic glucose production and improves insulin sensitivity, lowering HbA1c by up to 1.5%. Sulfonylureas stimulate insulin release, while GLP-1 receptor agonists like semaglutide promote weight loss and cardiovascular benefits.
SGLT2 inhibitors, such as empagliflozin, promote glucose excretion via urine, reducing heart failure risk by 35% per EMPA-REG trials. For type 1 or advanced type 2 diabetes, insulin therapy is essential. Rapid-acting insulins (e.g., lispro) handle mealtime boluses, while basal insulins (e.g., glargine) provide steady coverage. Continuous subcutaneous insulin infusion via pumps offers precise dosing.
Monitoring and Acute Management
Self-monitoring of blood glucose (SMBG) or continuous glucose monitoring (CGM) systems tracks trends, enabling timely adjustments. Target HbA1c under 7% guides long-term control. In acute hyperglycemia exceeding 250 mg/dL with symptoms like polyuria or fatigue, patients administer correction insulin doses per sliding scales.
For emergencies like DKA—marked by ketones and acidosis—hospitalization involves IV fluids, insulin infusion, and electrolyte correction. Potassium monitoring prevents hypokalemia during treatment.
Conclusion
Treating high blood sugar demands a multifaceted approach tailored to individual needs, integrating lifestyle, medications, and vigilant monitoring. Collaboration with healthcare providers ensures personalized plans, reducing complication risks and improving quality of life. Early intervention and adherence empower those with diabetes to thrive, underscoring prevention’s role in averting crises.